SCHEMBL14975876

SCHEMBL14975876

CCCCOC(=O)N(c1ccc(N)cc1)C1CCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.50
LMNA P02545 3/20 0.50
CYP1A2 P05177 3/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C19 P33261 2/20 0.50
CYP2C9 P11712 1/20 0.50
PDE4D Q08499 1/20 0.50
ALDH1A1 P00352 4/20 0.45
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
MAPT P10636 2/20 0.45
CYP2D6 P10635 3/20 0.44
CHRM2 P08172 1/20 0.44
HTR1A P08908 1/20 0.44
GAA P10253 1/20 0.44
DRD3 P35462 1/20 0.44
SCN1A P35498 1/20 0.44
SLC6A3 Q01959 1/20 0.44
KCNH2 Q12809 1/20 0.44
SCN2A Q99250 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6120637 0.86 LMNA (0.44) TSHRLMNACYP1A2CYP3A4CYP2C19
SCHEMBL27590825 0.83 LSS (0.42) TSHRLMNACYP1A2CYP2C19ALDH1A1
SCHEMBL28033051 0.77 LMNA (0.58) TSHRLMNACYP1A2CYP3A4CYP2C19
SCHEMBL6082056 0.76 TSHR (0.56) TSHRLMNACYP1A2CYP3A4CYP2C19
SCHEMBL14976496 0.75 MEN1 (0.40) LMNAALDH1A1NPC1RAB9AMAPT
SCHEMBL6740971 0.74 CYP3A4 (0.54) TSHRLMNACYP1A2CYP3A4CYP2C19
SCHEMBL6740204 0.73 CYP3A4 (0.52) TSHRLMNACYP1A2CYP3A4CYP2C19
SCHEMBL30193146 0.72 LMNA (0.45) TSHRLMNACYP1A2CYP3A4CYP2C19
SCHEMBL11807077 0.71 LMNA (0.50) LMNAALDH1A1NPC1RAB9AMAPT
SCHEMBL16682367 0.71 LMNA (0.56) TSHRLMNACYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013078254-A1 BICYCLIC HETEROARYL DERIVATIVES AS KINASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2013-05-30 WO disclosed